ARTICLE | Company News
Celgene, Inception IBD deal
December 14, 2015 8:00 AM UTC
Inception partnered with Celgene to discover and develop therapeutics for ulcerative colitis (UC) and Crohn’s disease. Inception is eligible for up to $40 million in cash payments. Celgene obtained a ...